<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03349697</url>
  </required_header>
  <id_info>
    <org_study_id>BIOT1200</org_study_id>
    <nct_id>NCT03349697</nct_id>
  </id_info>
  <brief_title>Phyllantus Amarus for the Protection of Liver Health</brief_title>
  <official_title>Phyllantus Amarus for the Protection of Liver Health: A Randomized, Double Blind, Placebo Controlled Crossover Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotropics Malaysia Berhad</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biotropics Malaysia Berhad</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a randomized, double-blind, placebo controlled crossover study. The purpose of
      this study is to assess the ability of Phyllantus amarus to protect the liver against
      temporary stress including oxidative stress induced by alcohol consumption.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 13, 2010</start_date>
  <completion_date type="Actual">October 16, 2010</completion_date>
  <primary_completion_date type="Actual">October 16, 2010</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compare the effect of Phyllantus versus placebo on HS CRP levels in blood</measure>
    <time_frame>26 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Compare the effect of Phyllantus versus placebo on the inflammatory cytokines in blood</measure>
    <time_frame>26 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Compare the effect of Phyllantus versus placebo on liver function levels in blood</measure>
    <time_frame>26 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Compare the effect of Phyllantus versus placebo on glutatoine peroxidase (GSH-Px) in blood</measure>
    <time_frame>26 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compare the effect of Phyllantus versus placebo on hangover severity score</measure>
    <time_frame>26 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare the effect of Phyllantus versus placebo on profile of mood states (POMS)</measure>
    <time_frame>26 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare the effect of Phyllantus versus placebo on cognitive performance tests</measure>
    <time_frame>26 days</time_frame>
    <description>Using the CNS Vital Signs System</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare the effect of Phyllantus versus placebo on sleep quality</measure>
    <time_frame>26 days</time_frame>
    <description>Based on the number of hours slept</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Compare the effect of Phyllantus versus placebo on adverse events</measure>
    <time_frame>36 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Compare the effect of Phyllantus versus placebo on a comprehensive metabolic panel (CMP) analysis</measure>
    <time_frame>26 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Compare the effect of Phyllantus versus placebo on complete blood count</measure>
    <time_frame>26 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Compare the effect of Phyllantus versus placebo on Urinalaysis</measure>
    <time_frame>26 days</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Active Product then Placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo then Active Product</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Phyllantus amarus</intervention_name>
    <arm_group_label>Active Product then Placebo</arm_group_label>
    <arm_group_label>Placebo then Active Product</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Active Product then Placebo</arm_group_label>
    <arm_group_label>Placebo then Active Product</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy male or female 21-50 years of age, inclusive.

          -  Subject consumes at least 5 servings of alcohol per week on a regular basis.

          -  Minimum POMS score of 15.

          -  Access to a computer and internet

          -  Subject is willing to maintain his or her habitual food and beverage intake (other
             than substitution of study food for similar products) and physical activity patterns
             throughout the study period.

          -  Body mass index (BMI) between 20 and 30 kg/m2.

          -  Subject is willing and able to comply with the alcohol consumption requirements.

          -  Subjects willing to stay in the clinic for two overnight stays

          -  Judged by the Investigator to be in general good health on the basis of medical
             history.

          -  Subject understands the study procedures and signs forms providing informed consent to
             participate in the study and authorization for release of relevant protected health
             information to the study investigator.

        Exclusion Criteria:

          -  Any Liver condition including Hepatitis, Fatty Liver, Liver Disease.

          -  Liver Function greater than three times the upper level limit of normal

          -  History or record of aggressive or violent behavior

          -  Any significant GI condition that would potentially interfere with the evaluation of
             the study product [e.g., Ulcerative Colitis or Crohn's Disease, inflammatory bowel
             disease, irritable bowel syndrome, Clinically significant Gastritis, history of upper
             GI bleed (bleeding ulcer), chronic constipation (defined as &lt;3 bowel movements per
             week), history of frequent diarrhea, history of surgery for weight loss,
             gastroparesis, clinically important lactose intolerance].

          -  Clinically significant renal, hepatic, endocrine (including diabetes mellitus),
             cardiac, pulmonary, pancreatic, neurologic, or biliary disorder.

          -  Known allergy or sensitivity to any ingredients in the study products.

          -  Extreme dietary habits (e.g., vegan, Atkins Diet, etc.).

          -  Recent (within two weeks of visit 1, week -1) episode of acute gastrointestinal
             illness such as nausea, vomiting, or diarrhea.

          -  Uncontrolled hypertension (systolic blood pressure _160 mm Hg or diastolic blood
             pressure _100 mm Hg at visit 1, week -1).

          -  History or presence of cancer in the prior two years, except for non-melanoma skin
             cancer.

          -  Any major trauma or surgical event within three months of visit 1, week -1.

          -  Recent use of antibiotics (within 6 weeks).

          -  Females who are pregnant, lactating, planning to be pregnant during the study period.

          -  Recent history of (within 12 months) or strong potential for alcohol or substance
             abuse. Alcohol abuse will be defined as &gt;14 drinks per week (1 drink =12 ounces beer,
             5 ounces wine, or 1 Â½ ounces distilled spirits).

          -  Participation in a clinical study with exposure to any non-registered drug product
             within 30 days prior.

          -  Individual has a condition the Investigator believes would interfere with his or her
             ability to provide informed consent, comply with the study protocol, which might
             confound the interpretation of the study results or put the person at undue risk

          -  Current active respiratory illness at the time of screening

          -  Any immune system disorders

          -  Subjects with a history of perforation of the stomach or intestines

          -  Subjects who have had gastric bypass surgery

          -  Untreated Hypothyroidism

          -  Subjects with active eating disorder including anorexia nervosa, bulimia, and/or
             obsessive compulsive eating disorders

          -  Spinal cord injuries
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tengku Shahrir Tengku Adnan</last_name>
    <role>Study Director</role>
    <affiliation>Biotropics Malaysia Berhad</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sanjay Udani, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medicus Research, LLC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medicus Research, LLC</name>
      <address>
        <city>Northridge</city>
        <state>California</state>
        <zip>91325</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 17, 2017</study_first_submitted>
  <study_first_submitted_qc>November 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 21, 2017</study_first_posted>
  <last_update_submitted>November 22, 2017</last_update_submitted>
  <last_update_submitted_qc>November 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Liver Health</keyword>
  <keyword>Hangover</keyword>
  <keyword>Herbal supplement</keyword>
  <keyword>Liver function</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

